Ikarian Capital »

Contineum Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 283k 11.43

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Contineum Therapeutics

Suvretta Capital Management
RA Capital Management
Johnson & Johnson
Franklin Resources
Vanguard Group
Balyasny Asset Management
Commodore Capital
FMR
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management

View all funds holding Contineum Therapeutics